NxStage Medical has patented a blood treatment system with multiple pumps for low and high blood flow treatments. The system includes a multi-stream treatment machine and an accessory fluid circuit with parallel blood flow paths. This innovation allows for efficient extracorporeal blood treatment and extracorporeal membrane oxygenation. GlobalData’s report on NxStage Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on NxStage Medical, was a key innovation area identified from patents. NxStage Medical's grant share as of February 2024 was 69%. Grant share is based on the ratio of number of grants to total number of patents.
Blood treatment system with multiple pumps for parallel blood flow
A recently granted patent (Publication Number: US11918720B2) discloses a multiple treatment fluid stream system designed for extracorporeal blood treatment and extracorporeal membrane oxygenation. The system includes a multi-stream treatment machine with at least two pumps, one being a blood pump and the other a multiple-fluid pump for various fluids. An accessory fluid circuit with parallel pumping tube segments splits the blood into two streams, which then combine before reaching the blood oxygenator. The system can be configured for delivering hemodialysis treatment and includes instructions for operating the multiple-fluid pump in reverse for different treatment modes.
Additionally, the patent describes a method for performing blood treatments using the disclosed system. The method involves connecting different fluid circuits to the machine for specific treatments, such as hemodialysis or hemofiltration, with dilution of blood using replacement fluid or anti-coagulant. The blood is pumped in parallel flow paths to a blood oxygenator, where the two portions of blood from the pumping tube segments combine before entering the oxygenator. This method allows for efficient and customizable blood treatments, enhancing the overall treatment process for patients in need of extracorporeal blood treatment and oxygenation.
To know more about GlobalData’s detailed insights on NxStage Medical, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
